Myomo (MYO) Asset Writedowns and Impairment (2017 - 2025)

Myomo (MYO) has reported Asset Writedowns and Impairment for 8 consecutive years, with $103779.0 the latest figure, recorded in Q3 2025.

• For the quarter ending Q3 2025, Asset Writedowns and Impairment changed N/A year-over-year to $103779.0; the trailing twelve-month figure through Sep 2025 stood at $193822.0 (up 821.56% YoY), and the FY2024 full-year result was $43657.0, up 53.72% from the prior year.
• Asset Writedowns and Impairment climbed to $103779.0 in Q3 2025 per MYO's latest filing, from $51643.0 in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $103779.0 in Q3 2025 and bottomed at -$374.0 in Q3 2023.
• Historically, Asset Writedowns and Impairment has averaged $31694.4 across 4 years, with a median of $20925.0 in 2022.
• The sharpest annual moves came in 2023 and 2024: Asset Writedowns and Impairment slumped 50.14% in 2023, then jumped 143.42% in 2024.
• Over 4 years, Asset Writedowns and Impairment stood at $26075.0 in 2022, then sank by 39.5% to $15775.0 in 2023, then surged by 143.42% to $38400.0 in 2024, then jumped by 170.26% to $103779.0 in 2025.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $103779.0, $51643.0, and $38400.0 for Q3 2025, Q1 2025, and Q4 2024 respectively.